Cargando…

Enhanced effector function of cytotoxic cells in the induced sputum of COPD patients

BACKGROUND: We have previously shown that NK (CD56(+)CD3(-)) and NKT-like (CD56(+)CD3(+)) cells are reduced in both numbers and cytotoxicity in peripheral blood. The aim of the present study was to investigate their numbers and function within induced sputum. METHODS: Induced sputum cell numbers and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Urbanowicz, Richard A, Lamb, Jonathan R, Todd, Ian, Corne, Jonathan M, Fairclough, Lucy C
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2891678/ https://www.ncbi.nlm.nih.gov/pubmed/20540777 http://dx.doi.org/10.1186/1465-9921-11-76

Ejemplares similares

Altered effector function of peripheral cytotoxic cells in COPD
por: Urbanowicz, Richard A, et al.
Publicado: (2009)

Differential Activation of Killer Cells in the Circulation and the Lung: A Study of Current Smoking Status and Chronic Obstructive Pulmonary Disease (COPD)
por: Wang, Jia, et al.
Publicado: (2013)

Systems biology coupled with label-free high-throughput detection as a novel approach for diagnosis of chronic obstructive pulmonary disease
por: Richens, Joanna L, et al.
Publicado: (2009)

Increased levels of soluble interleukin-6 receptor and CCL3 in COPD sputum
por: Ravi, Arjun K, et al.
Publicado: (2014)

Protein networks in induced sputum from smokers and COPD patients
por: Baraniuk, James N, et al.
Publicado: (2015)

Sputum cell count: biomarkers in the differentiation of asthma, COPD and asthma–COPD overlap
por: Gao, Jie, et al.
Publicado: (2017)

Sputum microbiology predicts health status in COPD
por: Braeken, Dionne CW, et al.
Publicado: (2016)

Comparing microbiota profiles in induced and spontaneous sputum samples in COPD patients
por: Tangedal, Solveig, et al.
Publicado: (2017)

Influence of Cell Quality on Inflammatory Biomarkers in COPD Sputum Supernatant
por: Pedersen, Frauke, et al.
Publicado: (2021)

Characterization of sputum biomarkers for asthma–COPD overlap syndrome
por: Gao, Jing, et al.
Publicado: (2016)

Blood and sputum eosinophils in COPD; relationship with bacterial load
por: Kolsum, Umme, et al.
Publicado: (2017)

Smoking status and anti-inflammatory macrophages in bronchoalveolar lavage and induced sputum in COPD
por: Kunz, Lisette IZ, et al.
Publicado: (2011)

Comparison of inflammatory markers in induced and spontaneous sputum in a cohort of COPD patients
por: Tangedal, Solveig, et al.
Publicado: (2014)

The sputum transcriptome better predicts COPD exacerbations after the withdrawal of inhaled corticosteroids than sputum eosinophils
por: Ditz, Benedikt, et al.
Publicado: (2021)

IL-26 in the induced sputum is associated with the level of systemic inflammation, lung functions and body weight in COPD patients
por: Savchenko, Lesia, et al.
Publicado: (2018)

Rating sputum cell quality in clinical trials for asthma and COPD treatment
por: Pedersen, Frauke, et al.
Publicado: (2019)

Bacteria and sputum inflammatory cell counts; a COPD cohort analysis
por: Beech, Augusta S., et al.
Publicado: (2020)

Dyspnea assessment and adverse events during sputum induction in COPD
por: Makris, Demosthenes, et al.
Publicado: (2006)

Glutathione S-transferase omega in the lung and sputum supernatants of COPD patients
por: Harju, Terttu H, et al.
Publicado: (2007)

Anxiety and depression in COPD patients and correlation with sputum and BAL cytology
por: Tetikkurt, Cuneyt, et al.
Publicado: (2011)

Sputum Bacterial and Fungal Dynamics during Exacerbations of Severe COPD
por: Su, Jin, et al.
Publicado: (2015)

Bacterial flora in the sputum and comorbidity in patients with acute exacerbations of COPD
por: Boixeda, Ramon, et al.
Publicado: (2015)

Microparticles in sputum of COPD patients: a potential biomarker of the disease?
por: Lacedonia, Donato, et al.
Publicado: (2016)

Reduced sputum expression of interferon-stimulated genes in severe COPD
por: Hilzendeger, Clarissa, et al.
Publicado: (2016)

Validation of the breathlessness, cough and sputum scale to predict COPD exacerbation
por: DeVries, Rebecca, et al.
Publicado: (2016)

Short term dynamics of the sputum microbiome among COPD patients
por: Sinha, Rohita, et al.
Publicado: (2018)

Sputum Streptococcus pneumoniae is reduced in COPD following treatment with benralizumab
por: George, Leena, et al.
Publicado: (2019)

Characterization of sputum biomarkers for asthma–COPD overlap syndrome [Erratum]
Publicado: (2017)

Sputum microbiome profiling in COPD: beyond singular pathogen detection
por: Ditz, Benedikt, et al.
Publicado: (2020)

Validation of Sputum Biomarker Immunoassays and Cytokine Expression Profiles in COPD
por: Mulvanny, Alex, et al.
Publicado: (2022)

Genetic regulators of sputum mucin concentration and their associations with COPD phenotypes
por: Van Buren, Eric, et al.
Publicado: (2023)

A Microfluidic Platform for Evaluating Neutrophil Chemotaxis Induced by Sputum from COPD Patients
por: Wu, Jiandong, et al.
Publicado: (2015)

Responsiveness of blood and sputum inflammatory cells in Japanese COPD patients, non-COPD smoking controls, and non-COPD nonsmoking controls
por: Kawayama, Tomotaka, et al.
Publicado: (2016)

Differential DAMP release was observed in the sputum of COPD, asthma and asthma-COPD overlap (ACO) patients
por: Huang, Xiaolin, et al.
Publicado: (2019)

Enhanced expression of natural cytotoxicity receptors on cytokine-induced memory-like natural killer cells correlates with effector function
por: Carreira-Santos, Sofía, et al.
Publicado: (2023)

Sputum Moraxella catarrhalis strains exhibit diversity within and between COPD subjects
por: George, Leena M, et al.
Publicado: (2018)

Analysis of Sputum Markers in the Evaluation of Lung Inflammation and Functional Impairment in Symptomatic Smokers and COPD Patients
por: Paone, Gregorino, et al.
Publicado: (2011)

Multi analyte profiling and variability of inflammatory markers in blood and induced sputum in patients with stable COPD
por: Aaron, Shawn D, et al.
Publicado: (2010)

Granulocyte–macrophage colony-stimulating factor expression in induced sputum and bronchial mucosa in asthma and COPD
por: Saha, S, et al.
Publicado: (2009)

Sputum Gene Expression Reveals Dysregulation of Mast Cells and Basophils in Eosinophilic COPD
por: Winter, Natasha A, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nl6vr8uce51ti49ai9oq48tdiv